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Background
The National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population is a 
series of publications that provide ongoing assessment o f the U.S. population’s nutrition status by 
measuring blood and urine levels of diet-and-nutrition biochemical indicators.
This is the second report in this series. The Centers for Disease Control and Prevention’s (CDC) 
Division of Laboratory Sciences at the National Center for Environmental Health (NCEH/DLS) 
conducted the laboratory analyses for 58 biochemical indicators presented in this 2012 report. CD C 
measured these indicators in specimens from a representative sample of the U.S. population during 
all or part o f the four-year period from 2003 through 2006. Where available, data are also presented 
on changes of biochemical indicator levels over time since 1999. Similarly, data are also presented on 
the prevalence of low or high biochemical indicator levels during 2003-2006, and on changes in the 
prevalence over time since 1999.
The first report of this series was published in July 2008 and it contains information on 27 
biochemical indicators from all or part of the four-year period from 1999 through 2002. Both 




• Fat-soluble vitamins and nutrients
• Trace elements (iron indicators 
and iodine)
• Isoflavones and lignans
New report features
• Central 95% reference intervals
• Graphic representation of age 
patterns






• Iron status: Transferrin receptor 
and body iron
The specimens for the Second Nutrition Report were collected by C D C ’s National Health and 
Nutrition Examination Survey (NHANES), which is conducted by the National Center for Health 
Statistics (NCHS). NHANES is a series of surveys designed to collect data on the health and 
nutrition status o f the U.S. population.
This report covers one important facet in the assessment of nutrition status of the U.S. population: 
biochemical measurements. Other nutrition-related aspects from NHANES, such as dietary intake, 
supplement usage, hematologic measurements, and anthropometric body measurements are not covered.
Executive Summary 1
Public health uses
The primary objective o f the Second Nutrition Report is to inform public health scientists and 
policy makers about the levels of biochemical indicators o f diet and nutrition in the general U.S. 
population and in selected subpopulations. These data will help physicians, scientists, and public 
health officials assess inadequate or excess intake and will inform analyses on the relation between 
biochemical indicators and health outcomes. O ther objectives and potential public health uses of the 
information include the following:
• Establishing and improving upon existing population reference levels that can be used to 
determine whether a person or a group of people has an unusually high or low level of a 
biochemical indicator of diet and nutrition.
• Determining whether the nutrition status o f special population groups, such as minorities, 
children, women o f childbearing age, or the elderly is different from that of other groups, or 
whether such nutrition status needs improvement.
• Tracking trends over time in the population’s biochemical indicator levels.
• Assessing the effectiveness of public health efforts to improve the diet and nutrition status of 
the U.S. population.
• Guiding research to perform more in-depth analyses of the NHANES data and to generate 
hypotheses for future nutrition and human health studies.
Data presented for biochemical indicators
The Second Nutrition Report contains tables and figures of descriptive statistics on the distribution of 
blood and urine levels during all or part of the four-year period from 2003 through 2006 for each 
diet-and-nutrition biochemical indicator. Statistics include unadjusted geometric means and selected 
percentiles with confidence intervals. For some biochemical indicators, additional information is 
included, as available, in the form of:
• Tables and figures describing biochemical indicator levels across survey cycles during all or 
part of the eight-year period from 1999 through 2006. Statistics include unadjusted geometric 
means and selected percentiles with confidence intervals.
• Tables describing the prevalence of low or high levels o f selected biochemical indicators 
during all or part o f the four-year period from 2003 through 2006 and tables describing the 
prevalence across survey cycles during all or part of the eight-year period from 1999 through 
2006. Statistics include unadjusted percentages with confidence intervals and estimated total 
number of persons affected.
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Interpreting the data
Blood and urine levels of biochemical 
indicators can help in assessing the 
adequacy o f intake for the U.S. 
population. These measurements indicate 
cumulative intakes from foods, some 
fortified with micronutrients (e.g., 
iron, thiamin, riboflavin, niacin, folate, 
vitamin A, vitamin D), and from dietary 
supplements that contain vitamins, 
minerals, or both. However, blood or 
urine levels of biochemical indicators can 
also be influenced by factors other than
diet, such as various diseases or exposures. For those nutrients without defined adequate intakes (e.g., 
carotenoids, isoflavones), biochemical indicators are useful for assessing intake without regard to 
adequacy.
Dietary deficiencies are well documented, and they have characteristic signs and symptoms. In 
addition, recent findings have determined that less than optimal biochemical levels have been 
associated with risks of adverse health effects. These health effects include cardiovascular disease, 
stroke, impaired cognitive function, cancer, eye diseases, poor bone health, and other conditions. 
Adverse health effects, including toxicity, are also possible from consuming excess amounts of certain 
nutrients and data to assist in the assessment of excessive intake is a feature of this report.
Determining the levels o f a biochemical indicator that may indicate risk for disease and the levels 
that are of negligible health concern requires future research studies that are separate from this 
report. In collaboration with other agencies and institutions, CD C  encourages, and itself conducts 
research on the relationship between biochemical indicators and health effects.
Executive Summary 3
New information on prevalence of nutrient deficiencies
In NHANES 2003-2006, 10% or less of the general U.S. population had nutrition deficiencies for 
selected indicators (Fig. 1). However, for most nutrition indicators, the prevalence varied by age, 
gender, or race/ethnicity. For example, children and adolescents were rarely deficient in vitamin 
B12 (< 1%), while older adults were more likely to be deficient (4%). Men were more likely to be 
vitamin C deficient (7%) compared to women (5%). Non-Hispanic black (31%) and Mexican- 
American (12%) people were more likely to be vitamin D deficient compared to non-Hispanic white 
people (3%).
• Vitamin B6 (serum pyridoxal-5’-phosphate < 20 nmol/L), iron (serum body iron < 0 mg/kg), 
and vitamin D (serum 25-hydroxyvitamin D < 30 nmol/L) are the three nutrients assessed in 
this report with the highest prevalence o f deficiency.
• Vitamin A (serum retinol < 20 |ig/dL), vitamin E (serum alpha-tocopherol < 500 |ig/dL), and 
folate (red blood cell folate < 95 ng/mL) are nutrients with the lowest prevalence of deficiency 
of less than 1%.
• Vitamin C (serum ascorbic acid < 11.4 |imol/L) and vitamin B12 (serum cobalamin < 200 pg/ 
mL) are nutrients with intermediate prevalence o f deficiency.
Where we have data from 8 years of NHANES (1999-2006), we noticed that the prevalence of 
nutrient deficiencies hasn’t changed over that time period. Future reports may provide information 
on nutrient levels extending over a longer period o f time.
Vitamin B6 (>1 y) 10.5 1---------
Iron (women 12-49 y) 9.5 1------------ 1
Vitamin D (>1 y) 8.1 1 1
Iron (1-5 y) 6.7 1 1
Vitamin C (>6 y) 6 1--------------- 1
Vitamin B12_[>1 y) 2 1-----1
Vitamin A (>6 y) <1
Vitamin E (>6 y) <1
Folate (>1 y) <1
0 2 4 6 8 10 12 14
Prevalence of deficiency (%)
Figure 1. Prevalence estimates o f  nutrient deficiencies in U.S. persons, National Health and Nutrition Examination Survey, 
2003—2006. Error bars represent 95%  confidence intervals. Nutrition indicators were measured in different age (e.g., 1 y  and  older, 6  
y  and  older) and population groups (e.g., women 12-49 y  o f  age, children 1-5 y  o f  age). Cutoffvalues used to estimate prevalence are: 
serumpyridoxal-5’-phosphate < 2 0  nmol/L, serum body iron < 0 mg/kg, serum 25-hydroxyvitamin D  < 3 0  nmol/L, serum ascorbic 
acid < 114. fimol/L, serum cobalamin < 2 0 0 pg/mL, serum retinol < 2 0  fg /dL , serum alpha-tocopherol < 500  fg /dL , and red blood 
cell folate < 95  ng/mL.
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Folate levels rise after food fortification, decreasing folate 
deficiency to < 1%
Folate belongs to the group of water-soluble B vitamins that occur naturally in leafy green vegetables, 
fruits, and dried beans and peas. Folic acid is the synthetic form of folate found in supplements and 
added to fortified foods. Serum folate levels provide information on recent intake, while red blood cell 
(RBC) folate levels are indicative of body folate stores and long-term nutrition status. Adequate folate 
status is especially important during pregnancy, infancy, and other periods when cells rapidly divide and 
grow. To reduce the risk of neural-tube defects in newborns, the U.S. Food and Drug Administration 
introduced mandatory folic acid fortification of enriched cereal grain products in 1998.
Blood folate levels in the U.S. population showed the following demographic  
patterns:
• O f all age gro ups, o ld e r person s had the highest blood folate levels.
• Fem ales had g e n e rally  h igher levels than m ales.
• N o n-H ispanic blacks had the lowest, n o n -H isp an ic  w h ites had the 
highest, and M exican A m erican s had in term ediate folate status.
Continuous monitoring of the effect of the U.S. folic acid fortification program on blood folate 
levels is of great public health interest.
• Post 1998, blood folate levels increased by about 50% across race/ethnic groups (Fig. 2). From 
1999-2002 to 2003-2006, blood folate levels decreased slightly (< 10%) in each race/ethnic 
group, likely as a result of the intentional small reduction in the amount o f folic acid added to 
foods during this time period (Fig. 2).
• Before fortification, folate deficiency was about 10-12%  in women o f childbearing age, but 
after fortification, folate deficiency dropped to less than 1% in the U.S. population and in 
women of childbearing age of all race/ethnic groups.
Figure 2. Age-adjusted geometric mean levels o f  RBC 
folate in the U.S. population aged 4 years and older by 
gender or race/ethnicity, National Health and Nutrition 
Examination Survey, 1988-2006. Error bars represent 
95% confidence intervals. Within a demographic group, 
bars not sharing a common letter differ (p < 0.05).
Total Males Females Mexican Non- Non­




Vitamin D deficiency is closely related to race/ethnicity
Vitamin D is naturally found in only a few foods, such as fish-liver oils, fatty fishes, mushrooms, 
egg yolks, and liver. In the United States, vitamin D is commonly added to milk and other 
foods. Ultraviolet light from the sun helps people photosynthesize vitamin D in the skin, which 
is then transported to the liver and converted to 25-hydroxyvitamin D. Clinicians use serum 
25-hydroxyvitamin D to determine a person’s vitamin D status because it is a good reflection of 
cumulative effects o f exposure to sunlight and dietary intake. Vitamin D is essential for good bone 
health, and it may be important for muscle strength and protecting against cancer and type 2 
diabetes. These benefits of vitamin D are currently under active investigation.
Serum 25-hydroxyvitam in D levels in the U.S. population showed the  
following demographic patterns:
• Levels g e n e rally  decreased as age increased.
• M ales and fem ales had sim ilar levels.
• A m on g the three race /e th n ic  gro ups, n o n -H isp an ic  blacks had the 
low est 25-hyd ro xyvitam in D levels and n o n -H isp an ic  w h ites had the 
highest levels.
Clinical data show that non-Hispanic blacks have better bone health-greater bone density and fewer 
fractures-than other race/ethnic groups. However in NHANES 2003-2006, non-Hispanic blacks 
had the highest prevalence of vitamin D deficiency (serum 25-hydroxyvitamin D levels less than 30 
nmol/L) (Fig. 3). Further research is needed to explain this unusual finding. Non-Hispanic blacks and 
Mexican Americans had the highest prevalence of low serum 25-hydroxyvitamin D levels categorized 
as at-risk for inadequacy (30 to less than 50 nmol/L) compared to non-Hispanic whites (Fig. 3).
Mexican Non- Non- Mexican Non- Non-
American Hispanic Hispanic American Hispanic Hispanic
black white black white
< 30 nmol/L 30 to  < 50 nmol/L
Figure 3. Age-adjusted prevalence estimates o f  serum 25-hydroxyvitamin D  levels less than 3 0  a n d 3 0  to less than 5 0  nmol/L in the 
U.S. population aged 1 year and older by race/ethnicity, National Health and  Nutrition Examination Survey, 2003—2006. Error bars 
represent 95%  confidence intervals. Within each vitamin D  status category, bars not sharing a common letter differ (p < 0.05).
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First-time measurements of 24 plasma fatty acids, 
including heart-healthy fatty acids, in the U.S. population
Most fatty acids can be synthesized by the human body from carbohydrates. However, humans are 
incapable of de novo synthesis of n-6 and n-3 polyunsaturated fatty acids. Thus, linoleic (18:2n-6) and 
apha-linolenic (18:3n-3) acid are called “essential” polyunsaturated fatty acids. Both of these fatty 
acids are metabolized to longer-chain, more highly unsaturated forms. Fatty acids with no double 
bonds are referred to as saturated fatty acids, while those with one double bond are monounsaturated 
fatty acids. Currently, intense debate surrounds the question of whether reduction in dietary saturated 
fatty acids reduces the risk of cardiovascular disease. Lowering dietary intake of saturated fatty acids to 
no more than 10% of caloric intake and replacing them with mono- and polyunsaturated fatty acids is 
recommended to reduce the risk of cardiovascular disease.
These first-tim e plasma fa tty  acids levels in the U.S. population showed the  
following demographic patterns:
• In general, y o u n g e r ad u lts had low er levels of fatty acids.
• Plasm a levels of fatty acids w ere g e n e rally  sim ilar in m en and w o m en .
• For m ost fatty acids, no con sistent race/e th n ic  pattern w as found.
H e a r t - h e a lt h y  n -3  p o ly u n s a t u r a t e d  f a t t y  a c id  le v e ls  in  p la s m a  d iffe r  b y  r a c e /e t h n ic it y :
Geometric mean levels of eicosapentaenoic acid (EPA), which is typically derived from seafood and 
supplements, were higher in fasted non-Hispanic blacks and whites compared to Mexican-American 
adults (Fig. 4, Panel A). In addition, plasma levels of the related long-chain polyunsaturated 
docosahexaenoic acid (DHA) were higher in non-Hispanic black compared to Mexican-American 
and non-Hispanic white adults (Fig. 4, Panel B). Tracking fatty acid levels over time will show 
progress toward more heart-healthy diets.
A. B.











Mexican American Non-Hispanic black Non-Hispanic white
Figure 4. Geometric mean plasma levels o f  eicosapentaenoic (EPA, panel A ) and  docosahexaenoic (DHA, panel B) acid in the U.S. 
population from  fasted adults aged 2 0  years and older by race/ethnicity, National Health and Nutrition Examination Survey, 2003­













First-time measurement of new iron marker improves 
assessment of iron deficiency in Americans
Iron is needed for the formation o f hemoglobin, the protein in red blood cells that carries oxygen 
to tissues. Iron deficiency (ID) is linked to adverse consequences, such as reduced physical capacity, 
poor pregnancy outcomes, and negative effects on cognitive development among infants and 
adolescents and can progress to anemia if not treated. Low serum ferritin is a sensitive indicator of 
ID, but ferritin is affected by inflammation and levels do not track well with the progression of ID to 
anemia once iron stores are depleted. Serum soluble transferrin receptor (sTfR) levels start to increase 
after iron stores are depleted; they are indicative of functional ID and less affected by inflammation. 
Measuring this new marker and calculating the ratio of sTfR to ferritin, so-called body iron, allows 
assessment of the full spectrum of ID in the presence o f inflammation.
Levels o f serum ferritin and sTfR in the U.S. population showed the following  
demographic patterns:
• C hildren had the low est ferritin and highest sTfR levels com pared to 
other age groups.
• Regardless of the in dicato r selected, the likelih o od o f being iron 
deficien t varied by race/e th n ic  group.
• W hile children and w o m en  o f ch ild b e a rin g  age w ere at risk for ID, m en 
w ere at risk for iron excess.
New data from NHANES 2003-2006 allowed for the first time assessment of the iron status of 
children and women of childbearing age using body iron. Body iron is in a positive balance 
(> 0 mg/kg) when there is residual storage iron or in a negative balance (< 0 mg/kg) when there is 
functional ID.
The prevalence of ID based on low body iron (< 0 mg/kg) was higher in Mexican-American children 
compared to non-Hispanic black and non-Hispanic white children; it was higher in Mexican- 
American and non-Hispanic black women aged 12-49 years compared to non-Hispanic white 
women (Fig. 5).
Figure 5. Age-adjusted prevalence estimates o f low body iron 
(< 0 mg/kg) in children and women by race/ethnicity, National 
Health and Nutrition Examination Survey, 2003—2006. Error 
bars represent 95% confidence intervals. Bars not sharing a com­
mon letter differ within children and women (p < 0.05). | b
Mexican Non- Non- 
American Hispanic Hispanic 
black white
Children 1-5 years
Mexican Non- Non- 
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Women of childbearing age have iodine levels bordering 
on insufficiency
Iodine, a trace element found in soil, is an essential component of the thyroid hormones involved 
in regulating the body’s metabolic processes related to normal growth and development. Across the 
world, iodized salt and seafood are the major dietary sources of iodine. In the United States, where 
addition o f iodine to salt is not mandatory, most people get their iodine from dairy products and 
bread. Iodine deficiency is the most preventable cause of mental retardation in the world. Iodine 
deficiency disorders include mental retardation, hypothyroidism, goiter, cretinism, and varying 
degrees of other growth and developmental abnormalities. Most dietary iodine absorbed in the body 
eventually appears in the urine; thus, urine iodine excretion is recommended for assessing recent 
dietary iodine intake.
Urine iodine levels in the U.S. population showed the following demographic 
patterns:
• The low est levels w ere o b served  in y o u n g  w o m en , w h ile  the highest 
levels w ere o b served  in children.
• No con sistent pattern w as o b served  w ith regard to race/ethnicity.
• Urine io dine levels have been relatively stable since the late 1980s.
The iodine intake of the U.S. population appeared to be adequate on the basis of median urine 
iodine levels. However, women aged 20-39 years had the lowest iodine intake, just slightly above 
insufficient intake (Fig. 6). Young women merit special attention to ensure the best possible brain 
development of the fetus during pregnancy.
While no age group had a median urine iodine level that represented excessive iodine intake, boys 
6-11 years o f age had the highest intake, and the upper confidence limit o f the median was just 
slightly within the range of excessive intake (Fig. 6).
Males Females
Age (years)
Figure 6. Median levels o f  urine iodine in the U.S. population aged 6  years and  older by age group and gender associated with 
estimated iodine intake, National Health and Nutrition Examination Survey, 2001—2006. Error bars represent 95%  confidence 
intervals.
Executive Summary 9
First-time assessment of acrylamide exposure in the U.S. 
population
Acrylamide is a chemical naturally found in starchy foods that are cooked at high temperatures (above 
120°C) and low-moisture conditions, such as those used for baking or frying. Foods that contain high 
acrylamide levels include potato chips, crackers, snacks, and coffee. Acrylamide is present in tobacco 
smoke, and it is an industrial chemical. In the body, some acrylamide is metabolized to glycidamide, 
which is an epoxide of acrylamide. Because glycidamide reacts with DNA, it is considered a genotoxic 
agent. Acrylamide has been categorized as reasonably anticipated to be a human carcinogen.
The lifelong exposure of most of the population to acrylamide through food and smoking has 
raised concerns about its potential health effects at low levels of intake. Measurement of acrylamide 
hemoglobin adduct levels provides information both about acrylamide exposure and metabolism.
The first-time acrylamide hemoglobin adduct levels in the U.S. population  
showed the following demographic patterns:
• H e m o g lo b in  a d d u ct levels w ere d etectab le  in nearly all blood sam ples 
m easured.
• We o b served  no con sistent age, gender, or race/e th n icity  patterns for 
the h e m o g lo b in  a d d u ct levels.
• How ever, d e m o g ra p h ic  differences em erged for the g lycid am id e-to - 
acrylam id e  h e m o g lo b in  a d d u ct ratios.
Children had higher glycidamide-to-acrylamide hemoglobin adduct ratios compared to adolescents 
and adults, suggesting differences in acrylamide metabolism or metabolic rate among age groups1. 
Non-Hispanic blacks had lower hemoglobin adduct ratios compared to non-Hispanic whites and 
Mexican Americans, which may indicate differences in polymorphisms of the genes involved in phase 
II detoxification of acrylamide and glycidamide.1
More research is needed to better understand factors influencing acrylamide metabolism and the 
relationship between acrylamide exposure and health risks.
10
1 Vesper HW, Caudill SP, Osterloh JD , et al. Exposure o f  the U.S. population to acrylamide in the N ational H ealth and N utrition  
Exam ination Survey 2003—2004. Environ Health Perspect. 2010;118:278-283.
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Plans for future N u t r i t i o n  R e p o r t s
C D C ’s goal is to make new biochemical nutrition information available as soon as possible to the 
public and to the scientific community. To meet this goal, CD C  periodically releases a new issue 
of the Nutrition Report and also publishes biochemical nutrition information in peer-reviewed 
publications. The Nutrition Report series provides biochemical nutrition information starting in 
1999 through the latest available data at the time o f the report release. Future plans include releasing 
data on additional indicators and providing more information on the nutrition status in population 
groups defined by age, sex, and race or ethnicity.
For the most up-to-date biochemical nutrition information, including the series of published 
reports as well as a list of peer-reviewed publications, users can view the Nutrition Report web site 
(http://www.cdc.gov/nutritionreport/).
About CDC's Nutritional Biomarkers Branch
The Nutritional Biomarkers Branch (NBB) develops and improves laboratory methods and analyzes 
essential nutrients (e.g., vitamins), nonessential nutrients (e.g., certain fatty acids), and dietary 
bioactive compounds (e.g., isoflavones and lignans) to evaluate nutrition status and its relationship 
to health. For many of these nutrients and dietary compounds, NBB produces population-based 
exposure levels segmented by age, sex, and race or ethnicity.
NBB reports nearly 100,000 test results every year for a wide range of nutrition biomarkers measured 
in NHANES and other studies. In collaboration with CD C colleagues, NBB also plays an active 
role in evaluating the worldwide burden of micronutrient deficiencies, such as deficiencies in folate, 
vitamin A, and iron. Billions o f people around the world are affected by micronutrient deficiencies 
that may cause birth defects, 
learning disabilities, mental 
retardation, reduced immunity, 
blindness, poor work capacity, or 
premature death. The laboratory 
provides training and technical 
assistance on questions about 
laboratory analysis and field 
logistics in preparation for national 
nutrition surveys in countries such 
as Argentina, Dominican Republic,
Iraq, Kenya, Laos, Malawi,
Nicaragua, Oman, Papua New 
Guinea, South Africa, Ukraine,
Uzbekistan, Yemen, and Zambia.
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Diet-and-nutrition indicators in the Second Nutrition Report*
W a t e r - S o lu b le  V it a m in s  a n d  R e la t e d  
B io c h e m ic a l C o m p o u n d s
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Lignoceric acid (24:0) 
Monounsaturated
Myristoleic acid (14:1n-5)





Nervonic acid (24:1n-9) 
Polyunsaturated
Linoleic acid (18:2n-6) 
alpha-Linolenic acid (18:3n-3) 
gamma-Linolenic acid (18:3n-6) 
Eicosadienoic acid (20:2n-6) 
homo-gamma-Linolenic acid (20:3n-6) 
Arachidonic acid (20:4n-6) 
Eicosapentaenoic acid (20:5n-3) 
Docosatetraenoic acid (22:4n-6) 
Docosapentaenoic-3 acid (22:5n-3) 
Docosapentaenoic-6 acid (22:5n-6) 
Docosahexaenoic acid (22:6n-3)
* Indicates N EW  biochemical indicators or groups of indicators in the Second Nutrition Report
12 2nd National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
